A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers

S. A. Narod, N. Tung, J. Lubinski, T. Huzarski, M. Robson, Henry T. Lynch, S. L. Neuhausen, P. Ghadirian, C. Kim-Sing, P. Sun, W. D. Foulkes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history and family history of cancer. Risk factors are more likely to be present in women with breast cancer than in women without breast cancer, and therefore the risk of cancer in the two breasts should not be independent. It is not clear to what extent modifying factors influence the risk of a first primary or a contralateral breast cancer in BRCA carriers. Methods We conducted a matched case-control study of breast cancer among 3920 BRCA1 or BRCA2 mutation carriers. We asked whether a past history of breast cancer in the contralateral breast was a risk factor for breast cancer. Results After adjustment for age, country of residence, and cancer treatment, a previous cancer of the right breast was found to be a significant risk factor for cancer of the left breast among BRCA1 or BRCA2 carriers (relative risk: 2.1; 95% confidence interval: 1.4 to 3.0; p <0.0001). Conclusions In a woman with a BRCA1 or BRCA2 mutation who is diagnosed with breast cancer, the risk of cancer in the contralateral breast depends on the first diagnosis. That observation supports the hypothesis that there are important genetic or non-genetic modifiers of cancer risk in BRCA carriers. Discovering risk modifiers might lead to greater personalization of risk assessment and management recommendations for BRCA-positive patients.

Original languageEnglish
Pages (from-to)64-68
Number of pages5
JournalCurrent Oncology
Volume21
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Breast Neoplasms
Mutation
Breast
Neoplasms
Reproductive History
Risk Management
Case-Control Studies
Observation
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Narod, S. A., Tung, N., Lubinski, J., Huzarski, T., Robson, M., Lynch, H. T., ... Foulkes, W. D. (2014). A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers. Current Oncology, 21(2), 64-68. https://doi.org/10.3747/co.21.1656

A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers. / Narod, S. A.; Tung, N.; Lubinski, J.; Huzarski, T.; Robson, M.; Lynch, Henry T.; Neuhausen, S. L.; Ghadirian, P.; Kim-Sing, C.; Sun, P.; Foulkes, W. D.

In: Current Oncology, Vol. 21, No. 2, 2014, p. 64-68.

Research output: Contribution to journalArticle

Narod, SA, Tung, N, Lubinski, J, Huzarski, T, Robson, M, Lynch, HT, Neuhausen, SL, Ghadirian, P, Kim-Sing, C, Sun, P & Foulkes, WD 2014, 'A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers', Current Oncology, vol. 21, no. 2, pp. 64-68. https://doi.org/10.3747/co.21.1656
Narod, S. A. ; Tung, N. ; Lubinski, J. ; Huzarski, T. ; Robson, M. ; Lynch, Henry T. ; Neuhausen, S. L. ; Ghadirian, P. ; Kim-Sing, C. ; Sun, P. ; Foulkes, W. D. / A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers. In: Current Oncology. 2014 ; Vol. 21, No. 2. pp. 64-68.
@article{f8a0e3978d734066a2cc92c7d70744f7,
title = "A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers",
abstract = "Background The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history and family history of cancer. Risk factors are more likely to be present in women with breast cancer than in women without breast cancer, and therefore the risk of cancer in the two breasts should not be independent. It is not clear to what extent modifying factors influence the risk of a first primary or a contralateral breast cancer in BRCA carriers. Methods We conducted a matched case-control study of breast cancer among 3920 BRCA1 or BRCA2 mutation carriers. We asked whether a past history of breast cancer in the contralateral breast was a risk factor for breast cancer. Results After adjustment for age, country of residence, and cancer treatment, a previous cancer of the right breast was found to be a significant risk factor for cancer of the left breast among BRCA1 or BRCA2 carriers (relative risk: 2.1; 95{\%} confidence interval: 1.4 to 3.0; p <0.0001). Conclusions In a woman with a BRCA1 or BRCA2 mutation who is diagnosed with breast cancer, the risk of cancer in the contralateral breast depends on the first diagnosis. That observation supports the hypothesis that there are important genetic or non-genetic modifiers of cancer risk in BRCA carriers. Discovering risk modifiers might lead to greater personalization of risk assessment and management recommendations for BRCA-positive patients.",
author = "Narod, {S. A.} and N. Tung and J. Lubinski and T. Huzarski and M. Robson and Lynch, {Henry T.} and Neuhausen, {S. L.} and P. Ghadirian and C. Kim-Sing and P. Sun and Foulkes, {W. D.}",
year = "2014",
doi = "10.3747/co.21.1656",
language = "English",
volume = "21",
pages = "64--68",
journal = "Current Oncology",
issn = "1198-0052",
publisher = "Multimed Inc.",
number = "2",

}

TY - JOUR

T1 - A prior diagnosis of breast cancer is a risk factor for breast cancer in brca1 and brca2 carriers

AU - Narod, S. A.

AU - Tung, N.

AU - Lubinski, J.

AU - Huzarski, T.

AU - Robson, M.

AU - Lynch, Henry T.

AU - Neuhausen, S. L.

AU - Ghadirian, P.

AU - Kim-Sing, C.

AU - Sun, P.

AU - Foulkes, W. D.

PY - 2014

Y1 - 2014

N2 - Background The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history and family history of cancer. Risk factors are more likely to be present in women with breast cancer than in women without breast cancer, and therefore the risk of cancer in the two breasts should not be independent. It is not clear to what extent modifying factors influence the risk of a first primary or a contralateral breast cancer in BRCA carriers. Methods We conducted a matched case-control study of breast cancer among 3920 BRCA1 or BRCA2 mutation carriers. We asked whether a past history of breast cancer in the contralateral breast was a risk factor for breast cancer. Results After adjustment for age, country of residence, and cancer treatment, a previous cancer of the right breast was found to be a significant risk factor for cancer of the left breast among BRCA1 or BRCA2 carriers (relative risk: 2.1; 95% confidence interval: 1.4 to 3.0; p <0.0001). Conclusions In a woman with a BRCA1 or BRCA2 mutation who is diagnosed with breast cancer, the risk of cancer in the contralateral breast depends on the first diagnosis. That observation supports the hypothesis that there are important genetic or non-genetic modifiers of cancer risk in BRCA carriers. Discovering risk modifiers might lead to greater personalization of risk assessment and management recommendations for BRCA-positive patients.

AB - Background The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history and family history of cancer. Risk factors are more likely to be present in women with breast cancer than in women without breast cancer, and therefore the risk of cancer in the two breasts should not be independent. It is not clear to what extent modifying factors influence the risk of a first primary or a contralateral breast cancer in BRCA carriers. Methods We conducted a matched case-control study of breast cancer among 3920 BRCA1 or BRCA2 mutation carriers. We asked whether a past history of breast cancer in the contralateral breast was a risk factor for breast cancer. Results After adjustment for age, country of residence, and cancer treatment, a previous cancer of the right breast was found to be a significant risk factor for cancer of the left breast among BRCA1 or BRCA2 carriers (relative risk: 2.1; 95% confidence interval: 1.4 to 3.0; p <0.0001). Conclusions In a woman with a BRCA1 or BRCA2 mutation who is diagnosed with breast cancer, the risk of cancer in the contralateral breast depends on the first diagnosis. That observation supports the hypothesis that there are important genetic or non-genetic modifiers of cancer risk in BRCA carriers. Discovering risk modifiers might lead to greater personalization of risk assessment and management recommendations for BRCA-positive patients.

UR - http://www.scopus.com/inward/record.url?scp=84898797420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898797420&partnerID=8YFLogxK

U2 - 10.3747/co.21.1656

DO - 10.3747/co.21.1656

M3 - Article

VL - 21

SP - 64

EP - 68

JO - Current Oncology

JF - Current Oncology

SN - 1198-0052

IS - 2

ER -